Thanks to a yearslong boom in the world of venture capital, keeping tabs on biotech means constantly reading that some so-called startup is suddenly worth more than $1 billion. But just who is putting the horns on all these unicorns?
Welcome back to “The Facts, STAT!”, a not-infrequent STAT video series in which our reporters briefly explain the need-to-know basics of issues in the world of health care and biotech.
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect